Name: Apabetalone
Text:
Apabetalone has been investigated for the treatment of Diabetes, Atherosclerosis, and Coronary Artery Disease.
APABETALONE is a small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications.
Properties:safety: Health Hazard
smiles: CC1=CC(=CC(=C1OCCO)C)C2=NC3=C(C(=CC(=C3)OC)OC)C(=O)N2
formula: C20H22N2O5
chem_properties: Molecular Weight: 370.4 g/mol
XLogP3: 2.3
Hydrogen Bond Donor Count: 2
Hydrogen Bond Acceptor Count: 6
Rotatable Bond Count: 6
Exact Mass: 370.15287181 Da
Monoisotopic Mass: 370.15287181 Da
Topological Polar Surface Area: 89.4
Heavy Atom Count: 27
Formal Charge: 0
Complexity: 542
Isotope Atom Count: 0
Defined Atom Stereocenter Count: 0
Undefined Atom Stereocenter Count: 0
Defined Bond Stereocenter Count: 0
Undefined Bond Stereocenter Count: 0
Covalently-Bonded Unit Count: 1
Compound Is Canonicalized: Yes 

